| Title |
Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series
|
|---|---|
| Published in |
Critical Care, July 2020
|
| DOI | 10.1186/s13054-020-03158-0 |
| Pubmed ID | |
| Authors |
Andreas Stallmach, Andreas Kortgen, Falk Gonnert, Sina M. Coldewey, Philipp Reuken, Michael Bauer |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 13% |
| Spain | 2 | 13% |
| Philippines | 1 | 7% |
| United Arab Emirates | 1 | 7% |
| Australia | 1 | 7% |
| Malaysia | 1 | 7% |
| Dominican Republic | 1 | 7% |
| Canada | 1 | 7% |
| United Kingdom | 1 | 7% |
| Other | 0 | 0% |
| Unknown | 4 | 27% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 9 | 60% |
| Practitioners (doctors, other healthcare professionals) | 4 | 27% |
| Scientists | 1 | 7% |
| Science communicators (journalists, bloggers, editors) | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 112 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 112 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 16 | 14% |
| Other | 12 | 11% |
| Researcher | 11 | 10% |
| Student > Master | 11 | 10% |
| Student > Postgraduate | 7 | 6% |
| Other | 21 | 19% |
| Unknown | 34 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 35 | 31% |
| Biochemistry, Genetics and Molecular Biology | 9 | 8% |
| Immunology and Microbiology | 8 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 7% |
| Nursing and Health Professions | 3 | 3% |
| Other | 13 | 12% |
| Unknown | 36 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 December 2022.
All research outputs
#1,300,228
of 25,387,668 outputs
Outputs from Critical Care
#1,105
of 6,555 outputs
Outputs of similar age
#36,117
of 413,492 outputs
Outputs of similar age from Critical Care
#55
of 204 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,555 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.8. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 413,492 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 204 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.